Spotlight

London's universities say ‘OpenSME’ to new support for capital's small businesses

A group of London's universities are launching a new collaboration – OpenSME – that seeks to make it easier for small and medium-sized enterprises (SMEs) to access the expertise and knowledge they offer.

Read full article



follow us on twitter


Spotlight

The Mayor appoints Professor Stephen Caddick to the London Enterprise Panel

We are pleased to confirm that Professor Stephen Caddick has been appointed to the new position on the LEP for a representative of London’s Higher Education sector.
More...

How to respond when the grand vision becomes a cold reality

New ventures are started for many reasons, with one of the most common routes beginning with someone doing a job they like in a big company and thinking they want to do it for themselves, but where do they go from there, asks Timothy Barnes, Director of UCL Enterprise Operations and UCL Advances. More...

Business letters: October 20

YOU say that turning university science projects into big companies is mostly impossible (“Imperial needs to pick more winners”, last week). Yet the acquisition of Spirogen by Astra Zeneca for $440m (£272m) last week shows that substantial returns to investors are possible from university research.
Read: The Sunday Times

UCL and Photobiotics announce partnership to tackle gastric cancer

UCL, Photobiotics pursue new approach to gastric cancer
A new collaboration between University College London (UCL) and PhotoBiotics, a targeted oncology company spun out from Imperial College London in the UK, is looking to develop a multifunctional agent for use in both the diagnosis and treatment of gastric cancer.
Read: PharmaTimes

Spirogen sold to AstraZeneca

AstraZeneca to pay $440m for UK biotech business
Pharmaceutical group makes acquisition in oncology group spun out of university
Read: Guardian
More...

Search UCL News